Business
Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics
Medical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Listed as a Top 5 Company in Hemp-Based CBD Market by Equity Research Firm Avise Analytics\nPR Newswire\nSAN DIEGO, Aug. 22, 2019\n\n\n\nSAN DIEGO, Aug. 22, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (\"the Company\") (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that equity research firm Avise Analytics, Ltd. (\"Avise Analytics\") ranked the Company as one of the Top 5 Companies in the Hemp-Based Cannabidiol (CBD) Market. \n\"It is an honor to once again be recognized as a leader in the cannabis industry and specifically the CBD market,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"Our company has continued to advocate for safe and legal CBD access across the world for the past decade and, as our efforts in several Latin American countries such as Mexico, Brazil and Paraguay, as well as throughout Europe have shown, we look forward to growing the company and becoming an even more prominent player in the global CBD market.\"\nAvise Analytics, founded in 2012, is an international provider of high-quality research and offers a comprehensive range of customized equity research outsourcing services, investment, financial and credit research outsourcing solutions. The firm authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies. Avise Analytics is an approved research contributor on premier institutional investor platforms including Thomson Reuters, S&P Global, Factset, and CapitalIQ. \nAs Avise Analytics points out in its report, the Company has many impressive accomplishments over the past year. Medical Marijuana, Inc. became the first company to have CBD products listed in the Prescribers' Digital Reference, a well-regarded educational resource for U.S...